1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-36M446
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Human Prothrombin Complex Market Insights and Forecast to 2028
BUY CHAPTERS

Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-36M446
Report
August 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Prothrombin Complex- Market Size

The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.

Human Prothrombin Complex- Market

Human Prothrombin Complex- Market

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
This report aims to provide a comprehensive presentation of the global market for Human Prothrombin Complex, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Prothrombin Complex by region & country, by Type, and by Application.
The Human Prothrombin Complex market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Prothrombin Complex.
Market Segmentation

Scope of Human Prothrombin Complex- Market Report

Report Metric Details
Report Name Human Prothrombin Complex- Market
Forecasted market size in 2031 US$ 4251 million
CAGR 11.8%
Forecasted years 2025 - 2031
Segment by Type
  • 500 IU/Vial
  • 600 IU/Vial
  • 1000 IU/Vial
  • Others
Segment by Application
  • Hemophilia B
  • Vitamin K Deficiency
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Human Prothrombin Complex in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Human Prothrombin Complex- Market size in 2031?

Ans: The Human Prothrombin Complex- Market size in 2031 will be US$ 4251 million.

What is the market share of major companies in Human Prothrombin Complex- Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Human Prothrombin Complex- Market share by type?

Ans: In terms of product, 500 IU/Vial is the largest segment, with a share over 50%.

Who are the main players in the Human Prothrombin Complex- Market report?

Ans: The main players in the Human Prothrombin Complex- Market are Takeda, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma

What are the Application segmentation covered in the Human Prothrombin Complex- Market report?

Ans: The Applications covered in the Human Prothrombin Complex- Market report are Hemophilia B, Vitamin K Deficiency, Others

What are the Type segmentation covered in the Human Prothrombin Complex- Market report?

Ans: The Types covered in the Human Prothrombin Complex- Market report are 500 IU/Vial, 600 IU/Vial, 1000 IU/Vial, Others

1 Market Overview
1.1 Human Prothrombin Complex Product Introduction
1.2 Global Human Prothrombin Complex Market Size Forecast
1.2.1 Global Human Prothrombin Complex Sales Value (2020-2031)
1.2.2 Global Human Prothrombin Complex Sales Volume (2020-2031)
1.2.3 Global Human Prothrombin Complex Sales Price (2020-2031)
1.3 Human Prothrombin Complex Market Trends & Drivers
1.3.1 Human Prothrombin Complex Industry Trends
1.3.2 Human Prothrombin Complex Market Drivers & Opportunity
1.3.3 Human Prothrombin Complex Market Challenges
1.3.4 Human Prothrombin Complex Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Prothrombin Complex Players Revenue Ranking (2024)
2.2 Global Human Prothrombin Complex Revenue by Company (2020-2025)
2.3 Global Human Prothrombin Complex Players Sales Volume Ranking (2024)
2.4 Global Human Prothrombin Complex Sales Volume by Company Players (2020-2025)
2.5 Global Human Prothrombin Complex Average Price by Company (2020-2025)
2.6 Key Manufacturers Human Prothrombin Complex Manufacturing Base and Headquarters
2.7 Key Manufacturers Human Prothrombin Complex Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Human Prothrombin Complex
2.9 Human Prothrombin Complex Market Competitive Analysis
2.9.1 Human Prothrombin Complex Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Human Prothrombin Complex Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 500 IU/Vial
3.1.2 600 IU/Vial
3.1.3 1000 IU/Vial
3.1.4 Others
3.2 Global Human Prothrombin Complex Sales Value by Type
3.2.1 Global Human Prothrombin Complex Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Human Prothrombin Complex Sales Value, by Type (2020-2031)
3.2.3 Global Human Prothrombin Complex Sales Value, by Type (%) (2020-2031)
3.3 Global Human Prothrombin Complex Sales Volume by Type
3.3.1 Global Human Prothrombin Complex Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Human Prothrombin Complex Sales Volume, by Type (2020-2031)
3.3.3 Global Human Prothrombin Complex Sales Volume, by Type (%) (2020-2031)
3.4 Global Human Prothrombin Complex Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hemophilia B
4.1.2 Vitamin K Deficiency
4.1.3 Others
4.2 Global Human Prothrombin Complex Sales Value by Application
4.2.1 Global Human Prothrombin Complex Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Human Prothrombin Complex Sales Value, by Application (2020-2031)
4.2.3 Global Human Prothrombin Complex Sales Value, by Application (%) (2020-2031)
4.3 Global Human Prothrombin Complex Sales Volume by Application
4.3.1 Global Human Prothrombin Complex Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Human Prothrombin Complex Sales Volume, by Application (2020-2031)
4.3.3 Global Human Prothrombin Complex Sales Volume, by Application (%) (2020-2031)
4.4 Global Human Prothrombin Complex Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Human Prothrombin Complex Sales Value by Region
5.1.1 Global Human Prothrombin Complex Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Human Prothrombin Complex Sales Value by Region (2020-2025)
5.1.3 Global Human Prothrombin Complex Sales Value by Region (2026-2031)
5.1.4 Global Human Prothrombin Complex Sales Value by Region (%), (2020-2031)
5.2 Global Human Prothrombin Complex Sales Volume by Region
5.2.1 Global Human Prothrombin Complex Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Human Prothrombin Complex Sales Volume by Region (2020-2025)
5.2.3 Global Human Prothrombin Complex Sales Volume by Region (2026-2031)
5.2.4 Global Human Prothrombin Complex Sales Volume by Region (%), (2020-2031)
5.3 Global Human Prothrombin Complex Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Human Prothrombin Complex Sales Value, 2020-2031
5.4.2 North America Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Human Prothrombin Complex Sales Value, 2020-2031
5.5.2 Europe Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Human Prothrombin Complex Sales Value, 2020-2031
5.6.2 Asia Pacific Human Prothrombin Complex Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Human Prothrombin Complex Sales Value, 2020-2031
5.7.2 South America Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human Prothrombin Complex Sales Value, 2020-2031
5.8.2 Middle East & Africa Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Prothrombin Complex Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Human Prothrombin Complex Sales Value
6.2.1 Key Countries/Regions Human Prothrombin Complex Sales Value, 2020-2031
6.2.2 Key Countries/Regions Human Prothrombin Complex Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Human Prothrombin Complex Sales Value, 2020-2031
6.3.2 United States Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Human Prothrombin Complex Sales Value, 2020-2031
6.4.2 Europe Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Human Prothrombin Complex Sales Value, 2020-2031
6.5.2 China Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.5.3 China Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Human Prothrombin Complex Sales Value, 2020-2031
6.6.2 Japan Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Human Prothrombin Complex Sales Value, 2020-2031
6.7.2 South Korea Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Human Prothrombin Complex Sales Value, 2020-2031
6.8.2 Southeast Asia Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Human Prothrombin Complex Sales Value, 2020-2031
6.9.2 India Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
6.9.3 India Human Prothrombin Complex Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Takeda
7.1.1 Takeda Company Information
7.1.2 Takeda Introduction and Business Overview
7.1.3 Takeda Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Takeda Human Prothrombin Complex Product Offerings
7.1.5 Takeda Recent Development
7.2 CSL
7.2.1 CSL Company Information
7.2.2 CSL Introduction and Business Overview
7.2.3 CSL Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 CSL Human Prothrombin Complex Product Offerings
7.2.5 CSL Recent Development
7.3 Grifols
7.3.1 Grifols Company Information
7.3.2 Grifols Introduction and Business Overview
7.3.3 Grifols Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Grifols Human Prothrombin Complex Product Offerings
7.3.5 Grifols Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Introduction and Business Overview
7.4.3 Octapharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Octapharma Human Prothrombin Complex Product Offerings
7.4.5 Octapharma Recent Development
7.5 Hualan Biological
7.5.1 Hualan Biological Company Information
7.5.2 Hualan Biological Introduction and Business Overview
7.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Hualan Biological Human Prothrombin Complex Product Offerings
7.5.5 Hualan Biological Recent Development
7.6 Meheco Xinxing Pharma
7.6.1 Meheco Xinxing Pharma Company Information
7.6.2 Meheco Xinxing Pharma Introduction and Business Overview
7.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Offerings
7.6.5 Meheco Xinxing Pharma Recent Development
8 Industry Chain Analysis
8.1 Human Prothrombin Complex Industrial Chain
8.2 Human Prothrombin Complex Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Prothrombin Complex Sales Model
8.5.2 Sales Channel
8.5.3 Human Prothrombin Complex Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Human Prothrombin Complex Market Trends
 Table 2. Human Prothrombin Complex Market Drivers & Opportunity
 Table 3. Human Prothrombin Complex Market Challenges
 Table 4. Human Prothrombin Complex Market Restraints
 Table 5. Global Human Prothrombin Complex Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Human Prothrombin Complex Revenue Market Share by Company (2020-2025)
 Table 7. Global Human Prothrombin Complex Sales Volume by Company (2020-2025) & (K Units)
 Table 8. Global Human Prothrombin Complex Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Human Prothrombin Complex Price by Company (2020-2025) & (M USD/Unit)
 Table 10. Key Manufacturers Human Prothrombin Complex Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Human Prothrombin Complex Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Human Prothrombin Complex
 Table 13. Global Human Prothrombin Complex Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Prothrombin Complex Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Human Prothrombin Complex Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Human Prothrombin Complex Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Human Prothrombin Complex Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Human Prothrombin Complex Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Human Prothrombin Complex Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
 Table 22. Global Human Prothrombin Complex Sales Volume by Type (2020-2025) & (K Units)
 Table 23. Global Human Prothrombin Complex Sales Volume by Type (2026-2031) & (K Units)
 Table 24. Global Human Prothrombin Complex Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Human Prothrombin Complex Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Human Prothrombin Complex Price by Type (2020-2025) & (M USD/Unit)
 Table 27. Global Human Prothrombin Complex Price by Type (2026-2031) & (M USD/Unit)
 Table 28. Global Human Prothrombin Complex Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Human Prothrombin Complex Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Human Prothrombin Complex Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Human Prothrombin Complex Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Human Prothrombin Complex Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Human Prothrombin Complex Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
 Table 34. Global Human Prothrombin Complex Sales Volume by Application (2020-2025) & (K Units)
 Table 35. Global Human Prothrombin Complex Sales Volume by Application (2026-2031) & (K Units)
 Table 36. Global Human Prothrombin Complex Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Human Prothrombin Complex Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Human Prothrombin Complex Price by Application (2020-2025) & (M USD/Unit)
 Table 39. Global Human Prothrombin Complex Price by Application (2026-2031) & (M USD/Unit)
 Table 40. Global Human Prothrombin Complex Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Human Prothrombin Complex Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Human Prothrombin Complex Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Human Prothrombin Complex Sales Value by Region (2020-2025) & (%)
 Table 44. Global Human Prothrombin Complex Sales Value by Region (2026-2031) & (%)
 Table 45. Global Human Prothrombin Complex Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
 Table 46. Global Human Prothrombin Complex Sales Volume by Region (2020-2025) & (K Units)
 Table 47. Global Human Prothrombin Complex Sales Volume by Region (2026-2031) & (K Units)
 Table 48. Global Human Prothrombin Complex Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Human Prothrombin Complex Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Human Prothrombin Complex Average Price by Region (2020-2025) & (M USD/Unit)
 Table 51. Global Human Prothrombin Complex Average Price by Region (2026-2031) & (M USD/Unit)
 Table 52. Key Countries/Regions Human Prothrombin Complex Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Human Prothrombin Complex Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Human Prothrombin Complex Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Human Prothrombin Complex Sales Volume, (2020-2025) & (K Units)
 Table 56. Key Countries/Regions Human Prothrombin Complex Sales Volume, (2026-2031) & (K Units)
 Table 57. Takeda Company Information
 Table 58. Takeda Introduction and Business Overview
 Table 59. Takeda Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
 Table 60. Takeda Human Prothrombin Complex Product Offerings
 Table 61. Takeda Recent Development
 Table 62. CSL Company Information
 Table 63. CSL Introduction and Business Overview
 Table 64. CSL Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
 Table 65. CSL Human Prothrombin Complex Product Offerings
 Table 66. CSL Recent Development
 Table 67. Grifols Company Information
 Table 68. Grifols Introduction and Business Overview
 Table 69. Grifols Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
 Table 70. Grifols Human Prothrombin Complex Product Offerings
 Table 71. Grifols Recent Development
 Table 72. Octapharma Company Information
 Table 73. Octapharma Introduction and Business Overview
 Table 74. Octapharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
 Table 75. Octapharma Human Prothrombin Complex Product Offerings
 Table 76. Octapharma Recent Development
 Table 77. Hualan Biological Company Information
 Table 78. Hualan Biological Introduction and Business Overview
 Table 79. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
 Table 80. Hualan Biological Human Prothrombin Complex Product Offerings
 Table 81. Hualan Biological Recent Development
 Table 82. Meheco Xinxing Pharma Company Information
 Table 83. Meheco Xinxing Pharma Introduction and Business Overview
 Table 84. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
 Table 85. Meheco Xinxing Pharma Human Prothrombin Complex Product Offerings
 Table 86. Meheco Xinxing Pharma Recent Development
 Table 87. Key Raw Materials Lists
 Table 88. Raw Materials Key Suppliers Lists
 Table 89. Human Prothrombin Complex Downstream Customers
 Table 90. Human Prothrombin Complex Distributors List
 Table 91. Research Programs/Design for This Report
 Table 92. Key Data Information from Secondary Sources
 Table 93. Key Data Information from Primary Sources


List of Figures
 Figure 1. Human Prothrombin Complex Product Picture
 Figure 2. Global Human Prothrombin Complex Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Human Prothrombin Complex Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Human Prothrombin Complex Sales Volume (2020-2031) & (K Units)
 Figure 5. Global Human Prothrombin Complex Sales Price (2020-2031) & (M USD/Unit)
 Figure 6. Human Prothrombin Complex Report Years Considered
 Figure 7. Global Human Prothrombin Complex Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Human Prothrombin Complex Players Sales Volume Ranking (2024) & (K Units)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Prothrombin Complex Revenue in 2024
 Figure 10. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. 500 IU/Vial Picture
 Figure 12. 600 IU/Vial Picture
 Figure 13. 1000 IU/Vial Picture
 Figure 14. Others Picture
 Figure 15. Global Human Prothrombin Complex Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 16. Global Human Prothrombin Complex Sales Value Market Share by Type, 2024 & 2031
 Figure 17. Global Human Prothrombin Complex Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
 Figure 18. Global Human Prothrombin Complex Sales Volume Market Share by Type, 2024 & 2031
 Figure 19. Global Human Prothrombin Complex Price by Type (2020-2031) & (M USD/Unit)
 Figure 20. Product Picture of Hemophilia B
 Figure 21. Product Picture of Vitamin K Deficiency
 Figure 22. Product Picture of Others
 Figure 23. Global Human Prothrombin Complex Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 24. Global Human Prothrombin Complex Sales Value Market Share by Application, 2024 & 2031
 Figure 25. Global Human Prothrombin Complex Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
 Figure 26. Global Human Prothrombin Complex Sales Volume Market Share by Application, 2024 & 2031
 Figure 27. Global Human Prothrombin Complex Price by Application (2020-2031) & (M USD/Unit)
 Figure 28. North America Human Prothrombin Complex Sales Value (2020-2031) & (US$ Million)
 Figure 29. North America Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
 Figure 30. Europe Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Europe Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
 Figure 32. Asia Pacific Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Human Prothrombin Complex Sales Value by Region (%), 2024 VS 2031
 Figure 34. South America Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
 Figure 35. South America Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
 Figure 36. Middle East & Africa Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
 Figure 37. Middle East & Africa Human Prothrombin Complex Sales Value by Country (%), 2024 VS 2031
 Figure 38. Key Countries/Regions Human Prothrombin Complex Sales Value (%), (2020-2031)
 Figure 39. Key Countries/Regions Human Prothrombin Complex Sales Volume (%), (2020-2031)
 Figure 40. United States Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
 Figure 41. United States Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
 Figure 42. United States Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
 Figure 43. Europe Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
 Figure 44. Europe Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
 Figure 45. Europe Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
 Figure 46. China Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
 Figure 47. China Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
 Figure 48. China Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
 Figure 49. Japan Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
 Figure 50. Japan Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
 Figure 51. Japan Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
 Figure 52. South Korea Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
 Figure 53. South Korea Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
 Figure 54. South Korea Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
 Figure 55. Southeast Asia Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
 Figure 56. Southeast Asia Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
 Figure 57. Southeast Asia Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
 Figure 58. India Human Prothrombin Complex Sales Value, (2020-2031) & (US$ Million)
 Figure 59. India Human Prothrombin Complex Sales Value by Type (%), 2024 VS 2031
 Figure 60. India Human Prothrombin Complex Sales Value by Application (%), 2024 VS 2031
 Figure 61. Human Prothrombin Complex Industrial Chain
 Figure 62. Human Prothrombin Complex Manufacturing Cost Structure
 Figure 63. Channels of Distribution (Direct Sales, and Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Assisted Spine Surgery Robot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30V16581
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global ENT Surgery Navigation Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11O6178
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Robotics in Laparoscopic Surgery Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7R6277
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Bone Allografts Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9I8785
Tue Sep 09 00:00:00 UTC 2025

Add to Cart